These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3897173)

  • 41. [Restudies on antibacterial activity of sulbenicillin against anaerobic bacteria (author's transl)].
    Umemura A; Isono M; Yamada N; Kobayashi T; Watanabe K; Ueno K
    Jpn J Antibiot; 1981 Jun; 34(6):976-9. PubMed ID: 7026824
    [No Abstract]   [Full Text] [Related]  

  • 42. Effect of Bacteroides fragilis on mortality induced by Escherichia coli in an experimental infection treated with cefotaxime, aztreonam or gentamicin.
    Soriano F; Ponte C; Santamaría M; Castilla C
    J Antimicrob Chemother; 1989 Mar; 23(3):383-8. PubMed ID: 2659565
    [TBL] [Abstract][Full Text] [Related]  

  • 43. ["In vitro" activity of ten antimicrobial agents against anaerobic bacteria. A collaborative study, 1999-2002].
    Litterio M; Bianchini H; Carloni G; Di Martino A; Fernández Canigia L; Greco G; Legaria C; Rollet R; Rossetti A; Predari SC; Castello L
    Rev Argent Microbiol; 2004; 36(3):130-5. PubMed ID: 15559195
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of the activity of imipenem and beta-lactams combined with sulbactam and clavulanic acid in beta-lactamase-producing strains of Bacteroides fragilis.
    Martín MA; Castillo AM; Liébana J; Marín A; Alados JC; Piédrola G
    J Hyg Epidemiol Microbiol Immunol; 1991; 35(2):189-97. PubMed ID: 1940333
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative efficacy of cefoperazone, cefoperazone plus sulbactam, ciprofloxacin, clindamycin, metronidazole, and penicillin G against anaerobic bacteria in an animal model.
    Moody JA; Fasching CE; Sinn LM; Gerding DN; Peterson LR
    J Lab Clin Med; 1990 Feb; 115(2):190-5. PubMed ID: 1967626
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Therapeutic efficacy and pharmacokinetic properties of ciprofloxacin in intra-abdominal abscesses caused by Bacteroides fragilis and Escherichia coli.
    Fu KP; Vince T; Bloom R; Gregory FJ; Hung PP
    Drugs Exp Clin Res; 1987; 13(8):493-6. PubMed ID: 3322752
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Variations in susceptibility to latamoxef(moxalactam) and cefoxitin within the Bacteroides fragilis group.
    Eley A; Greenwood D
    J Antimicrob Chemother; 1984 Mar; 13(3):245-55. PubMed ID: 6725175
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vitro activity of ertapenem: review of recent studies.
    Wexler HM
    J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii11-21. PubMed ID: 15150179
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Activity of FCE 22891 compared with cefuroxime axetil and cefixime in pulmonary and subcutaneous infections in mice.
    Rossi R; Castellani P; Younes G; Della Bruna C
    J Antimicrob Chemother; 1989 Mar; 23 Suppl C():149-55. PubMed ID: 2732136
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Therapeutic efficacy and pharmacokinetic properties of rifampicin in a Bacteroides fragilis intra-abdominal abscess.
    Fu KP; Lasinski ER; Zoganas HC; Kimble EF; Konopka EA
    J Antimicrob Chemother; 1984 Dec; 14(6):633-40. PubMed ID: 6520063
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of anaerobic infections: an overview.
    Finegold SM
    Scand J Infect Dis Suppl; 1985; 46():89-95. PubMed ID: 3865355
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chapter 3-3. Appendix: Drug-resistant anaerobes.
    ;
    J Infect Chemother; 2011 Jul; 17 Suppl 1():162-4. PubMed ID: 21728116
    [No Abstract]   [Full Text] [Related]  

  • 53. Quantification of the effect of anti-anaerobic drugs in experimental Bacteroides fragilis infection in mice.
    Dijkmans BA; Mattie H; Hermans J; van Furth R
    J Antimicrob Chemother; 1984 Jan; 13(1):79-86. PubMed ID: 6365877
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vivo efficacy of trovafloxacin against Bacteroides fragilis in mixed infection with either Escherichia coli or a vancomycin-resistant strain of Enterococcus faecium in an established-abscess murine model.
    Stearne LE; Gyssens IC; Goessens WH; Mouton JW; Oyen WJ; van der Meer JW; Verbrugh HA
    Antimicrob Agents Chemother; 2001 May; 45(5):1394-401. PubMed ID: 11302801
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antimicrobial susceptibility of anaerobic bacteria in Sweden in 1983.
    Nord CE; Olsson-Liljequist B
    Scand J Infect Dis Suppl; 1984; 43():44-9. PubMed ID: 6100139
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative in-vitro activity of Sch 34343, imipenem, cefpirome and cefotaxime.
    Bauernfeind A
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():155-64. PubMed ID: 3897170
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Susceptibility of anaerobic bacteria to five antimicrobial agents and demonstration of resistance of Bacteroides fragilis to clindamycin.
    Sofianou D; Douboyas J; Papapanagiotou J; Paradelis AG
    Methods Find Exp Clin Pharmacol; 1982; 4(3):173-7. PubMed ID: 7121128
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Levofloxacin plus metronidazole administered once daily versus moxifloxacin monotherapy against a mixed infection of Escherichia coli and Bacteroides fragilis in an in vitro pharmacodynamic model.
    Hermsen ED; Hovde LB; Sprandel KA; Rodvold KA; Rotschafer JC
    Antimicrob Agents Chemother; 2005 Feb; 49(2):685-9. PubMed ID: 15673752
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Synergistic effect of thiamphenicol and cephalothin on Bacterioides fragilis (author's transl)].
    Isono M; Aoki M; Kobayashi T; Marui T; Yamada H; Umemura A; Watanabe K; Ueno K
    Jpn J Antibiot; 1981 May; 34(5):647-50. PubMed ID: 7026821
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Penetration of cephalothin and cefoxitin into experimental infections with Bacteroides fragilis.
    O'Keefe JP; Tally FP; Barza M; Gorbach SL
    Rev Infect Dis; 1979; 1(1):106-12. PubMed ID: 318211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.